PCP
SAGE

Proficio Capital Partners’s Sage Therapeutics SAGE Stock Holding History

Proficio Capital Partners’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-92
Closed -$17K – 1252
2019
Q2 		$17K Buy
92
+19
+26% +$3.24K 0.01% 753
2019
Q1 		$12K Buy
73
+34
+87% +$4.92K ﹤0.01% 832
2018
Q4 		$4K Buy
39
+21
+117% +$2.4K ﹤0.01% 910
2018
Q3 		$3K Buy
18
+4
+29% +$617 ﹤0.01% 1055
2018
Q2 		$2K Buy
14
+10
+250% +$1.57K ﹤0.01% 1143
2018
Q1 		$1K Hold
4
– – ﹤0.01% 1229
2017
Q4 		$1K Buy
+4
New +$388 ﹤0.01% 1219

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Proficio Capital Partners's SAGE Position: Q3 2019 in Review

Proficio Capital Partners sold out of Sage Therapeutics (SAGE) in Q3 2019, closing a stake of 92 shares — an estimated $17K sold.

Proficio Capital Partners first reported a position in SAGE in Q4 2017 and held it in 7 quarters. The position peaked at $17K in Q2 2019. 285 funds tracked by Wall St. Rank hold SAGE as of Q3 2019.

  • Proficio Capital Partners reported no remaining Sage Therapeutics position as of Q3 2019 after selling out during the quarter.
  • Proficio Capital Partners sold 92 Sage Therapeutics shares in Q3 2019, an estimated $17K.
  • Proficio Capital Partners first reported a position in Sage Therapeutics in Q4 2017 and held it in 7 quarters.
  • Proficio Capital Partners's Sage Therapeutics position peaked at $17K in Q2 2019.
  • 285 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2019.

Based on Proficio Capital Partners's 13F filing for Q3 2019, filed 13 Nov 2019.